Главная › Колоректальный рак › Колорадо › Aurora
Клинические исследования Колоректальный рак в городе Aurora, CO
32 исследований по теме Колоректальный рак ищут участников в центрах в городе Aurora и поблизости (в радиусе около 30 миль). Откройте исследование, чтобы узнать критерии участия и контакты исследовательской группы.
Официальный текст исследования (на английском)
Ищете участников для исследования? Разместите его вверху страницы — $99 на 30 дней →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Набор участниковФаза 3
- Rocky Mountain Cancer Centers - Aurora /ID# 280112, Aurora
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Набор участников
- University of Colorado, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набор участниковФаза 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Набор участниковФаза 1/2
- University of Colorado Anschutz Medical Campus ( Site 0299), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0325), Aurora
- University of Colorado Anschutz Medical Campus ( Site 0326), Aurora
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Набор участниковФаза 3
- University of Colorado Denver Anschultz Medical Campus, Aurora
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
Набор участниковФаза 1
- University of Colorado Denver Anschultz Medical Campus, Aurora
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Набор участниковФаза 3
- UCHealth University of Colorado Hospital, Aurora
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
Набор участниковФаза 1
- UCHealth University of Colorado Hospital, Aurora
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Набор участниковФаза 1/2
- University of Colorado Hospital-Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набор участниковФаза 1/2
- University of Colorado Cancer Center, Aurora
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набор участниковФаза 1/2
- University of Colorado - Aurora Cancer Center, Aurora
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
Набор участниковФаза 1/2
- GSK Investigational Site, Aurora
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Набор участниковФаза 3
- Sarah Cannon Research Institute Scri Oncology Partners, Aurora
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
Набор участниковФаза 1
- University of Colorado Cancer Center, Aurora
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
Набор участниковФаза 1/2
- UCHealth University of Colorado Hospital, Aurora
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Набор участниковФаза 1
- University of Colorado, Aurora
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Набор участниковФаза 1/2
- Children's Hospital Colorado, Aurora
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Набор участниковНаблюдательное исследованиеПриглашаются здоровые добровольцы
- University of Colorado Denver, Aurora
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Набор участниковФаза 2
- University of Colorado Hospital- Anschutz Cancer Center Pavillion (ACP), Aurora
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Набор участниковНаблюдательное исследование
- University of Colorado Anschutz Medical Center, Aurora
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Набор участниковФаза 1/2
- University of Colorado, Aurora
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
Набор участниковПриглашаются здоровые добровольцы
- University of Colorado Hospital, Aurora
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Набор участниковФаза 1
- University of Colorado, Aurora
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
Набор участниковФаза 1/2
- GSK Investigational Site, Aurora
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Набор участниковФаза 3
- Rocky Mountain Cancer Centers, LLP, Aurora
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Набор участниковФаза 1
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora
- University of Colorado Hospital, Aurora
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Набор участниковФаза 1
- University of Colorado - Aurora Cancer Center, Aurora
LYL273 for Patients With Relapsed or Refractory mCRC
Набор участниковФаза 1/2
- University of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Набор участниковФаза 1/2
- University of Colorado Cancer Center, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Набор участниковНаблюдательное исследование
- Rocky Mountain Cancer Centers-Aurora, Aurora
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Набор участниковПриглашаются здоровые добровольцы
- DARTNet Institute, Aurora
Исследования Колоректальный рак в других городах
- Houston, TX102 исследований
- New York City, NY78 исследований
- Nashville, TN69 исследований
- Boston, MA63 исследований
- Los Angeles, CA59 исследований
- Arlington, VA52 исследований
- St. Louis, MO50 исследований
- San Antonio, TX46 исследований
- Philadelphia, PA44 исследований
- Grand Rapids, MI40 исследований
- Baldwin Park, CA37 исследований
- Chicago, IL34 исследований
Другие исследования в городе Aurora
- Рак (все виды)35 исследований
- Немелкоклеточный рак легкого31 исследование
- Рак молочной железы28 исследований
- Рак яичников25 исследований
- Метастатический рак25 исследований
- Сахарный диабет 1 типа23 исследований
- Ожирение22 исследований
- Рак простаты19 исследований
- Рак легких19 исследований
- Сердечная недостаточность18 исследований
- Меланома18 исследований
- Острый миелоидный лейкоз16 исследований
Источник: ClinicalTrials.gov, данные получены 6 окт. 2026 г.. Каждая исследование устанавливает свои критерии участия; решение о включении принимает исследовательская группа.